357 related articles for article (PubMed ID: 22560979)
41. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
[TBL] [Abstract][Full Text] [Related]
42. Beyond the short-term: clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients.
Bleiziffer S; Mazzitelli D; Opitz A; Hettich I; Ruge H; Piazza N; Lange R
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):310-7. PubMed ID: 22137802
[TBL] [Abstract][Full Text] [Related]
43. Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation.
Griese DP; Reents W; Diegeler A; Kerber S; Babin-Ebell J
Catheter Cardiovasc Interv; 2013 Nov; 82(5):E734-41. PubMed ID: 23765732
[TBL] [Abstract][Full Text] [Related]
44. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients.
Di Mario C; Eltchaninoff H; Moat N; Goicolea J; Ussia GP; Kala P; Wenaweser P; Zembala M; Nickenig G; Alegria Barrero E; Snow T; Iung B; Zamorano P; Schuler G; Corti R; Alfieri O; Prendergast B; Ludman P; Windecker S; Sabate M; Gilard M; Witowski A; Danenberg H; Schroeder E; Romeo F; Macaya C; Derumeaux G; Maggioni A; Tavazzi L;
EuroIntervention; 2013 Apr; 8(12):1362-71. PubMed ID: 23256965
[TBL] [Abstract][Full Text] [Related]
45. Clinical profile and outcome of patients with severe aortic stenosis at high surgical risk: single-center prospective evaluation according to treatment assignment.
Dvir D; Sagie A; Porat E; Assali A; Shapira Y; Vaknin-Assa H; Shafir G; Bental T; Nevzorov R; Battler A; Kornowski R
Catheter Cardiovasc Interv; 2013 Apr; 81(5):871-81. PubMed ID: 22915555
[TBL] [Abstract][Full Text] [Related]
46. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
[TBL] [Abstract][Full Text] [Related]
47. Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience.
Diemert P; Lange P; Greif M; Seiffert M; Conradi L; Massberg S; Blankenberg S; Reichenspurner H; Hagl C; Schmitz C; Schröfel H; Treede H; Schymik G; Kupatt C
Clin Res Cardiol; 2014 Mar; 103(3):183-90. PubMed ID: 24249313
[TBL] [Abstract][Full Text] [Related]
48. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
Borz B; Durand E; Godin M; Tron C; Canville A; Litzler PY; Bessou JP; Cribier A; Eltchaninoff H
Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
[TBL] [Abstract][Full Text] [Related]
49. Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation.
Ben-Dor I; Looser PM; Maluenda G; Weddington TC; Kambouris NG; Barbash IM; Hauville C; Okubagzi P; Corso PJ; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2012; 13(4):207-10. PubMed ID: 22818531
[TBL] [Abstract][Full Text] [Related]
50. Transfemoral aortic valve implantation of an Edwards Sapien XT valve in a patient with a mechanical mitral prosthesis.
Fraccaro C; Tarantini G; Napodano M; Gasparetto V; Iliceto S; Gerosa G; Isabella G
J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):669-70. PubMed ID: 21430546
[TBL] [Abstract][Full Text] [Related]
51. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.
Lefèvre T; Colombo A; Tchétché D; Latib A; Klugmann S; Fajadet J; De Marco F; Maisano F; Bruschi G; Bijuklic K; Nava S; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Schofer J
JACC Cardiovasc Interv; 2016 Jan; 9(1):68-75. PubMed ID: 26762913
[TBL] [Abstract][Full Text] [Related]
52. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
[TBL] [Abstract][Full Text] [Related]
53. The routine use of surgical exposure approach for trans-femoral implantation of the balloon expandable aortic prosthesis is associated to a low rate of vascular complications.
DE LA Torre Hernandez JM; Moreno R; Lee DH; Garcia Del Blanco B; Sanmartin JC; Garcia Blas S; Serra Garcia V; Gaviria K; Garcia I; Zueco J
J Cardiovasc Surg (Torino); 2016 Aug; 57(4):615-9. PubMed ID: 25673098
[TBL] [Abstract][Full Text] [Related]
54. Valve-in-valve implantation of Medtronic CoreValve prosthesis in patients with failing bioprosthetic aortic valves.
Linke A; Woitek F; Merx MW; Schiefer C; Möbius-Winkler S; Holzhey D; Rastan A; Ender J; Walther T; Kelm M; Mohr FW; Schuler G
Circ Cardiovasc Interv; 2012 Oct; 5(5):689-97. PubMed ID: 23048050
[TBL] [Abstract][Full Text] [Related]
55. Transfemoral aortic valve replacement with the SAPIEN XT valve: step-by-step.
Willson A; Toggweiler S; Webb JG
Semin Thorac Cardiovasc Surg; 2011; 23(1):51-4. PubMed ID: 21807299
[TBL] [Abstract][Full Text] [Related]
56. Fluoroscopic guide to an ideal implant position for Sapien XT and CoreValve during a valve-in-valve procedure.
Bapat VN; Attia RQ; Condemi F; Visagan R; Guthrie M; Sunni S; Thomas M
JACC Cardiovasc Interv; 2013 Nov; 6(11):1186-94. PubMed ID: 24139931
[TBL] [Abstract][Full Text] [Related]
57. Expandable sheath for transfemoral transcatheter aortic valve replacement: procedural outcomes and complications.
Borz B; Durand E; Tron C; Godin M; Canville A; Hauville C; Cribier A; Eltchaninoff H
Catheter Cardiovasc Interv; 2014 May; 83(6):E227-32. PubMed ID: 24403004
[TBL] [Abstract][Full Text] [Related]
58. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
59. Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access.
Greif M; Lange P; Mair H; Becker C; Schmitz C; Steinbeck G; Kupatt C
Clin Res Cardiol; 2012 Dec; 101(12):993-1001. PubMed ID: 22729757
[TBL] [Abstract][Full Text] [Related]
60. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
